Eculizumab Therapy in Children with Severe Hematopoietic Stem Cell Transplantation–Associated Thrombotic Microangiopathy

We recently observed that dysregulation of the complement system may be involved in the pathogenesis of hematopoietic stem cell transplantation–associated thrombotic microangiopathy (HSCT-TMA). These findings suggest that the complement inhibitor eculizumab could be a therapeutic option for this sev...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biol Blood Marrow Transplant
Main Authors: Jodele, Sonata, Fukuda, Tsuyoshi, Vinks, Alexander, Mizuno, Kana, Laskin, Benjamin L., Goebel, Jens, Dixon, Bradley P., Teusink, Ashley, Pluthero, Fred G., Lu, Lily, Licht, Christoph, Davies, Stella M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5436705/
https://ncbi.nlm.nih.gov/pubmed/24370861
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2013.12.565
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados